Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial

被引：48
|
作者：
Attard, Gerhardt [1 ,2 ,3 ]
Sydes, Matthew R. [4 ]
Mason, Malcolm D. [5 ]
Clarke, Noel W. [6 ]
Aebersold, Daniel [7 ]
de Bono, Johann S. [1 ,2 ,3 ]
Dearnaley, David P. [1 ,2 ,3 ]
Parker, Chris C. [1 ,2 ,3 ]
Ritchie, Alastair W. S. [4 ]
Russell, J. Martin [8 ]
Thalmann, George [9 ]
Cassoly, Estelle [10 ]
Millman, Robin
Matheson, David
Schiavone, Francesca [4 ]
Spears, Melissa R. [4 ]
Parmar, Mahesh K. B. [4 ]
James, Nicholas D. [11 ]
机构：
[1] Inst Canc Res, London SW3 6JB, England
[2] Royal Marsden NHS Fdn Trust, London, England
[3] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[4] UCL, MRC, Clin Trials Unit, London, England
[5] Cardiff Univ, Sch Med, Velindre Hosp, Cardiff CF10 3AX, S Glam, Wales
[6] Christie NHS Fdn Trust, Dept Urol, Manchester, Lancs, England
[7] Univ Bern, Bern, Switzerland
[8] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland
[9] Univ Hosp Bern, Dept Urol, CH-3010 Bern, Switzerland
[10] Swiss Grp Clin Canc Res SAKK, Bern, Switzerland
[11] Univ Warwick, Warwick, England
来源：
EUROPEAN UROLOGY | 2014年 / 66卷 / 05期
关键词：
METASTATIC PROSTATE-CANCER; INCREASED SURVIVAL; INHIBITOR; RECEPTOR; ACETATE;
D O I：
10.1016/j.eururo.2014.05.038
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：799 / 802
页数：4
相关论文
共 50 条
  • [1] Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone
    Nakazawa, Mary
    Antonarakis, Emmanuel S.
    Luo, Jun
    HORMONES & CANCER, 2014, 5 (05): : 265 - 273
  • [2] Docetaxel or abiraterone in combination with androgen deprivation therapy for metastatic prostate cancer
    Hammerer, P.
    Manka, L.
    UROLOGE, 2019, 58 (10): : 1185 - 1197
  • [3] Cost-effectiveness model of abiraterone plus prednisone, cabazitaxel plus prednisone and enzalutamide for visceral metastatic castration resistant prostate cancer therapy after docetaxel therapy resistance
    Barqawi, Yazan K.
    Borrego, Matthew E.
    Roberts, Melissa H.
    Abraham, Ivo
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (11) : 1202 - 1209
  • [4] Results of a Real-world Study of Enzalutamide and Abiraterone Acetate With Prednisone Tolerability (REAAcT)
    Shore, Neal D.
    Saltzstein, Daniel
    Sieber, Paul
    Mehlhaff, Bryan
    Gervasi, Lawrence
    Phillips, Jennifer
    Wong, Yu-Ning
    Pei, Huiling
    McGowan, Tracy
    CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 457 - +
  • [5] The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
    Nicola, Celeste
    Dubois, Martine
    Campart, Cynthia
    Al Sagheer, Tareq
    Desrues, Laurence
    Schapman, Damien
    Galas, Ludovic
    Lange, Marie
    Joly, Florence
    Castel, Helene
    CANCERS, 2021, 13 (14)
  • [6] Abiraterone, Orteronel, Enzalutamide and Docetaxel: Sequential or Combined Therapy?
    Chen, Ming-kun
    Liang, Zhi-jian
    Luo, Dao-Sheng
    Xue, Kang-yi
    Liao, De-ying
    Li, Zheshen
    Yu, Yuzhong
    Chen, Zhe-Sheng
    Zhao, Shan-Chao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Efficacy and safety of bipolar androgen therapy in mCRPC after progression on abiraterone or enzalutamide: A systematic review
    Xiong, Xingyu
    Qiu, Shi
    Yi, Xianyanling
    Xu, Hang
    Lei, Haoran
    Liao, Dazhou
    Bai, Shengjiang
    Peng, Ge
    Wei, Qiang
    Ai, Jianzhong
    Yang, Lu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (01) : 4.e19 - 4.e28
  • [8] Cardiovascular Toxicities of Androgen Deprivation Therapy
    Challa, Azariyas A.
    Calaway, Adam Christopher
    Cullen, Jennifer
    Garcia, Jorge
    Desai, Nihar
    Weintraub, Neal L.
    Deswal, Anita
    Kutty, Shelby
    Vallakati, Ajay
    Addison, Daniel
    Baliga, Ragavendra
    Campbell, Courtney M.
    Guha, Avirup
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (06)
  • [9] Novel and next-generation androgen receptor-directed therapies for prostate cancer: Beyond abiraterone and enzalutamide
    Bambury, Richard M.
    Rathkopf, Dana E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (08) : 348 - 355
  • [10] Evaluation of Response to Enzalutamide Consecutively After Abiraterone Acetate/Prednisone Failure in Patients With Metastatic Castration-resistant Prostate Cancer
    Emamekhoo, Hamid
    Barata, Pedro C.
    Edwin, Natasha C.
    Woo, Kaitlin M.
    Grivas, Petros
    Garcia, Jorge A.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : 429 - 436
12345